Tag Archive for: Astraveus SAS

Astraveus SAS has inked a strategic partnership with NecstGen to evaluate Lakhesys Benchtop Cell Factory for CAR-T therapy manufacturing. Meanwhile, German researchers present a solution to the design of hypoimmunogenic CAR-T cells.

French cell and gene therapy manufacturing specialist Astraveus SAS had raises €16.5m in seed money to advance its automated, microfluidic Cell and Gene Therapy manufacturing platform.